FDA approves two combination AIDS drugs delivered in a single pill form

08/3/2004 | USA Today · NYTimes.com

The FDA gave its approval to two combination AIDS drugs, making it more likely that patients in poor countries will have access to treatment through the U.S.' $15 billion emergency AIDS fund. Both pills combine two medicines into one pill to be taken once a day. Gilead Science's Truvada combines Viread and Emtriva and GlaxoSmithKline's Epzicom combines the company's HIV medicines Epivir and Ziagen.

View Full Article in:

USA Today · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA